Macrogenics

This is the first study in humans of an experimental drug called MGC028 for people with advanced solid tumors that have stopped responding to standard treatments. Researchers will test increasing doses in about 124 participants to find the highest safe amount and check for side e…

This is the first study in people testing a new cancer drug called MGC026. It aims to find a safe dose and see if the drug can help shrink tumors in adults with advanced solid tumors that have not responded to other treatments. The study will also check how the drug moves through…

This is the first study in people testing a new drug called MGD024 for several types of blood cancers that have come back or stopped responding to standard treatments. The main goal is to find a safe dose and understand how the drug works in the body. Researchers will also look f…

This study is testing an experimental immunotherapy drug called lorigerlimab for women with advanced ovarian and other gynecologic cancers that have stopped responding to standard platinum-based chemotherapy. About 60 participants will receive the drug through an IV every three w…